Pharmaceutical Supply Chain Fragility in Geopolitical and Economic Shifts

While the new tariffs are partially intended to combat the opioid crisis, these actions have broad implications for the pharmaceutical supply chain, challenging the industry to adapt to rising costs, disrupted flows & changing regulatory landscapes.